A New Approach page top left image

Biostatistics Consultation

- - - - NEWS - - - NEWS - - - NEWS - - - NEWS - - - NEWS - - - -

Thanks to a major new grant, we are pleased to announce that as of November 2012 Biostatistics Consultation will be open to investigators from beyond the Harvard community. Please refer to our revised “Access” guidelines below for further details.

High quality statistical support is important in the preparation of grant applications or study protocols for clinical trials. Such support typically is not readily available to investigators who are new to clinical trials. To address this weakness, the NeuroDiscovery Center provides expert consultation and collaboration on all biostatistical aspects of biomedical and clinical research applicable to neurological diseases.

Since its inception, the biostatistics program has collaborated with over 117 investigators on 289 projects from across the Harvard medical community. These projects have focused on a spectrum of neurodegenerative diseases and have included clinical trials, observational studies, basic science experiments and animal studies. The research has covered genetics, imaging and clinical endpoints such as progression and survival, and we have collaborated on study design for research grants and clinical trial protocols, data analysis and development of new statistical methods.

The biostatistics program is composed of a small team of MS and PhD level statisticians and is directed by Dr. Rebecca Betensky. For further information, please contact This e-mail address is being protected from spam bots, you need JavaScript enabled to view it directly.



Although Biostatistics primarily serves the Harvard community, including the 17 affiliated research hospitals, starting November 2012 we will also welcome users from other parts of the Massachusetts academic neurobiology research community.

When demand outstrips supply, we will prioritize access based on a combination of the relevance of the projects to the neurobiological, neurological and neuropsychiatric mission of the Center, and the source of the funds supporting the core.

In practice this is likely to mean that whereas the bulk of our users will continue to be from the wider Harvard-affiliate community, there will also be considerable access for non-Harvard, Massachusetts investigators.